Finance

Lists
MAP:ASX
Microba Life Sciences Ltd
A$0,037
0,00%
(0,00) 1D
4 Nov., 15:06:33 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for MAP...
Mkt. cap
27,48 m
Avg. vol.
329,02 k
Volume
0,00
52-wk high
A$0,10
52-wk low
A$0,03
EPS
-A$0,03
Shares outstanding
742,74 m
Mkt. cap
27,48 m
Avg. vol.
329,02 k
Volume
0,00
52-wk high
A$0,10
52-wk low
A$0,03
EPS
-A$0,03
Shares outstanding
742,74 m
News stories
From web sources and news partners
About Microba Life Sciences Ltd
CEO-
Employees-
Founded2017
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websitemicroba.com
Last report
16 Jul. 2026
Fiscal period
Q4 2026
- / -
Revenue / Est. (AUD)
3,72 m / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
3,66 m
3,66 m
3,72 m
3,72 m
Cost of goods sold
1,98 m
1,98 m
1,88 m
1,88 m
Cost of revenue
1,98 m
1,98 m
1,88 m
1,88 m
Research and development expenses
142,04 k
142,04 k
66,49 k
66,49 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,06 m
5,06 m
4,71 m
4,71 m
Operating expense
7,13 m
7,13 m
6,54 m
6,54 m
Total operating expenses
9,11 m
9,11 m
8,42 m
8,42 m
Operating income
-5,45 m
-5,45 m
-4,70 m
-4,70 m
Other non operating income
658,46 k
658,46 k
115,51 k
115,51 k
EBT including unusual items
-5,40 m
-5,40 m
-5,09 m
-5,09 m
EBT excluding unusual items
-5,03 m
-5,03 m
-5,06 m
-5,06 m
Income tax expense
-125,26 k
-125,26 k
-6,04 k
-6,04 k
Effective tax rate
2,32%
2,32%
0,12%
0,12%
Other operating expenses
828,78 k
828,78 k
652,54 k
652,54 k
Net income
-5,28 m
-5,28 m
-5,08 m
-5,08 m
Net profit margin
-144,21%
-144,21%
-136,65%
-136,65%
Earnings per share
-
-
-
-
Interest and investment income
105,25 k
105,25 k
52,55 k
52,55 k
Interest expense
-44,59 k
-44,59 k
-74,69 k
-74,69 k
Net interest expenses
60,66 k
60,66 k
-22,14 k
-22,14 k
Depreciation and amortization charges
1,10 m
1,10 m
1,10 m
1,10 m
EBITDA
-4,70 m
-4,70 m
-4,62 m
-4,62 m
Gain or loss from assets sale
-
-
48,64 k
48,64 k
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme